Rudwaleit, Martin
Article History
First Online: 16 June 2016
Competing interests
: The author declares that he has received consultancy fees and/or speakers' honoraria from Abbvie, Bristol–Myers–Squibb, Chugai, Janssen–Cilag, Merck, Sharp & Dohme, Novartis, Pfizer, Roche and UCB.